Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Maiz (Madrid, Spain), R. Giron (Madrid, Spain), E. Prats (Madrid, Spain), M. Clemente (Oviedo, Spain), E. Polverino (Barcelona, Spain), S. Caño (Barcelona, Spain), R. Cordovilla (Salamanca, Spain), J. Dorca (Barcelona, Spain), C. PeñAlver (Murcia, Spain), F. Baranda (Vizcaya, Spain), M. Martinez-Garcia (Valencia, Spain). Hyaluronic acid improves tolerability to 7% hypertonic saline solution in bronchiectasis patients. 1016

Member's Comments

No comment yet.

Related content which might interest you: 7% hypertonic saline and hyaluronic acid and in the treatment of infants mild-moderate bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011 A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005 Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Efficacy of nasal wash with saline solution 2% NaCl in children with high nasal resistance Source: Eur Respir J 2001; 18: Suppl. 33, 120s Year: 2001 The efficacy and tolerability of inhaled hypertonic saline in children with cystic fibrosis Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Efficacy of hypertonic saline solution in infant with acute bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Effects of intrabronchial terlipressin versus cold normal saline solution application in endobronchial bleeding Source: Annual Congress 2007 - Therapeutic bronchoscopy Year: 2007 A Comparison of 2% lidocaine viscous versus 2% lidocaine solution for improving discomfort and satisfaction in patients undergoing flexible bronchoscopy Source: International Congress 2017 – Nursing practice across respiratory care pathways Year: 2017 Comparison of magnesium sulfate to normal saline as a vehicle for nebulized salbutamol in children with acute asthma; a clinical trial Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives Year: 2008 Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Chest physiotherapy and breathing retraining Year: 2011 Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Clinical efficacy and safety evaluation of a novel seawater-based hypertonic solution in common cold patients Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Is nebulized saline a placebo in COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 184s Year: 2001 Inhaled hypertonic saline + hyaluronic acid (HSHA) and HS alone in patients with Cystic Fibrosis (CF): a 2 years retrospective analysis in Treviso’s CF Unit. Source: International Congress 2017 – Cystic fibrosis: clinical issues Year: 2017 Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 Montelukast attenuates the airway response to hypertonic saline in patients with moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002 Effect of inhaled hypertonic saline solution to treat infants hospitalized with viral bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011 Nebulised hypertonic saline in the treatment of viral bronchiolitis in infants Source: ISSN=ISSN 1810-6838, ISBN=, page=160 Year: 2007